Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Meta Platforms, Inc.FB · Entity 2790 | Chief Financial Officer | May 28, 2014 | May 30, 2014 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Meta Platforms, Inc.
Report date May 28, 2014 · Filed May 30, 2014
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 328,030 |
Ending reported balance
After 2014-05-29 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2014-05-28 · Sale · Disposed 11,700 · Balance 339,730 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Row 2 · 2014-05-29 · Sale · Disposed 11,700 · Balance 328,030 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy The Ebersman Family Trust UA DTD 5/29/02 | 318,924 |
Reported balance
Holding disclosure · report date 2014-05-28 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 318,924 F2: Shares held of record by The Ebersman Family Trust UA DTD 5/29/02, David A. Ebersman and Michelle Ebersman, Trustees. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy The Ebersman Family 2012 Irrevocable Trust | 108,090 |
Reported balance
Holding disclosure · report date 2014-05-28 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 108,090 F3: Shares held of record by The Ebersman Family 2012 Irrevocable Trust, David A. Ebersman and Michelle Ebersman, Trustees, the beneficiaries of which include the reporting person's minor children. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2: Shares held of record by The Ebersman Family Trust UA DTD 5/29/02, David A. Ebersman and Michelle Ebersman, Trustees.
F3: Shares held of record by The Ebersman Family 2012 Irrevocable Trust, David A. Ebersman and Michelle Ebersman, Trustees, the beneficiaries of which include the reporting person's minor children.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CASTLIGHT HEALTH, INC.
Report date February 17, 2022 · Filed February 18, 2022
Section 16 reporting ended · disclosed 2022-02-18. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-02-17 transaction · row 1
1 source rowRow 1 · 2022-02-17 · Disposition to issuer · Disposed 35,354 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated January 4, 2022, by and among the Issuer, Vera Whole Health, Inc. ("Vera Health"), and Carbon Merger Sub, Inc. (the "Merger Sub"), the Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Vera Health, effective as of February 17, 2022 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the Issuer's Class A common stock and Class B common stock was exchanged for $2.05 in cash (the "Merger Consideration") at the Effective Time. |
| Class B Common StockSEC Table I · non-derivative | IndirectBy family trust | 0 |
Reported balance
After 2022-02-17 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2022-02-17 · Disposition to issuer · Disposed 630,803 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated January 4, 2022, by and among the Issuer, Vera Whole Health, Inc. ("Vera Health"), and Carbon Merger Sub, Inc. (the "Merger Sub"), the Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Vera Health, effective as of February 17, 2022 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the Issuer's Class A common stock and Class B common stock was exchanged for $2.05 in cash (the "Merger Consideration") at the Effective Time. F2: The shares are held by The Ebersman Family Trust UTA dated 5/29/2002 of which the Reporting Person and his wife are co-trustees. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.00 · Expires 2024-03-12 | Direct | 0 |
Reported balance
After 2022-02-17 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-02-17 · Disposition to issuer · Disposed 25,000 · Balance 0 F4: The option exercise price is equal to or exceeds the Merger Consideration and therefore the option was automatically cancelled without consideration immediately prior to the Effective Time. F3: The option is fully vested and exercisable. |
| Class A Common StockSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-02-17 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-02-17 · Disposition to issuer · Disposed 28,571 · Balance 0 F5: Each share of Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect immediately prior to the Effective Time. The shares of Class A Common Stock have no expiration date. F6: Each share of Class A Common Stock converted into one (1) share of Class B Common Stock at the Effective Time. F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated January 4, 2022, by and among the Issuer, Vera Whole Health, Inc. ("Vera Health"), and Carbon Merger Sub, Inc. (the "Merger Sub"), the Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Vera Health, effective as of February 17, 2022 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the Issuer's Class A common stock and Class B common stock was exchanged for $2.05 in cash (the "Merger Consideration") at the Effective Time. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated January 4, 2022, by and among the Issuer, Vera Whole Health, Inc. ("Vera Health"), and Carbon Merger Sub, Inc. (the "Merger Sub"), the Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Vera Health, effective as of February 17, 2022 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the Issuer's Class A common stock and Class B common stock was exchanged for $2.05 in cash (the "Merger Consideration") at the Effective Time.
F2: The shares are held by The Ebersman Family Trust UTA dated 5/29/2002 of which the Reporting Person and his wife are co-trustees.
F3: The option is fully vested and exercisable.
F4: The option exercise price is equal to or exceeds the Merger Consideration and therefore the option was automatically cancelled without consideration immediately prior to the Effective Time.
F5: Each share of Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect immediately prior to the Effective Time. The shares of Class A Common Stock have no expiration date.
F6: Each share of Class A Common Stock converted into one (1) share of Class B Common Stock at the Effective Time.
MOMENTIVE GLOBAL INC.
Report date May 31, 2023 · Filed June 02, 2023 · Amendment
Section 16 reporting ended · disclosed 2023-06-02. Current position is not established by this disclosure.
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-05-31 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2023-05-31 · Disposition to issuer · Disposed 58,138 · Balance 0 F1: At the effective time of the merger contemplated by the Agreement and Plan of Merger, dated March 13, 2023, among Mercury Bidco LLC, Mercury Merger Sub, Inc. and Momentive Global Inc. (the "Company"), each issued and outstanding share of the Company's common stock was cancelled and converted into the right to receive an amount equal to $9.46 in cash. |
Filing footnotes · ownership attribution and instrument terms
F1: At the effective time of the merger contemplated by the Agreement and Plan of Merger, dated March 13, 2023, among Mercury Bidco LLC, Mercury Merger Sub, Inc. and Momentive Global Inc. (the "Company"), each issued and outstanding share of the Company's common stock was cancelled and converted into the right to receive an amount equal to $9.46 in cash.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 31, 2023 Filed Jun 2, 2023 20:08 UTC Amendment | MOMENTIVE GLOBAL INC. MNTV · Entity 112784 | Disposition to issuerCommon Stock | 58,138 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-034094 · doc4a.xml · nonDerivative · entry 1 EBERSMAN DAVID A · CIK 0001214123 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: At the effective time of the merger contemplated by the Agreement and Plan of Merger, dated March 13, 2023, among Mercury Bidco LLC, Mercury Merger Sub, Inc. and Momentive Global Inc. (the "Company"), each issued and outstanding share of the Company's common stock was cancelled and converted into the right to receive an amount equal to $9.46 in cash. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 19:45 UTC | MOMENTIVE GLOBAL INC. MNTV · Entity 112784 | Disposition to issuerCommon Stock | 58,138 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-034079 · doc4.xml · nonDerivative · entry 1 EBERSMAN DAVID A · CIK 0001214123 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: At the effective time of the merger contemplated by the Agreement and Plan of Merger, dated March 13, 2023, among Mercury Bidco LLC, Mercury Merger Sub, Inc. and Momentive Global Inc. (the "Company"), each issued and outstanding share of the Company's common stock was cancelled and converted into the right to receive an amount equal to $9.46 in cash. Read SEC document |
| June 07, 2022 Filed Jun 8, 2022 18:30 UTC | MOMENTIVE GLOBAL INC. MNTV · Entity 112784 | GrantCommon Stock | 10,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035191 · doc4.xml · nonDerivative · entry 1 EBERSMAN DAVID A · CIK 0001214123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,138 F1 · shares: Grant of Restricted Stock Units ("RSUs"). 1/4th of the total number of RSUs will vest on 08/15/2022 and 1/4th of the total number of RSUs will vest quarterly thereafter, subject to the Reporting Person's continued service to the Company until fully vested. F2 · balance_after: Certain of these securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the applicable vesting schedule and conditions. Read SEC document |
| February 17, 2022 Filed Feb 18, 2022 14:08 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Disposition to issuerClass A Common Stock · Derivative | 28,571 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-011148 · doc4.xml · derivative · entry 4 EBERSMAN DAVID A · CIK 0001214123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 28,571 shares Expires not disclosed F5 · derivative.exercise_price: Each share of Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect immediately prior to the Effective Time. The shares of Class A Common Stock have no expiration date. F6 · derivative.exercise_price: Each share of Class A Common Stock converted into one (1) share of Class B Common Stock at the Effective Time. F1 · price: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated January 4, 2022, by and among the Issuer, Vera Whole Health, Inc. ("Vera Health"), and Carbon Merger Sub, Inc. (the "Merger Sub"), the Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Vera Health, effective as of February 17, 2022 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the Issuer's Class A common stock and Class B common stock was exchanged for $2.05 in cash (the "Merger Consideration") at the Effective Time. F5 · derivative.exercise_date: Each share of Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect immediately prior to the Effective Time. The shares of Class A Common Stock have no expiration date. F6 · derivative.exercise_date: Each share of Class A Common Stock converted into one (1) share of Class B Common Stock at the Effective Time. F5 · derivative.expiration_date: Each share of Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect immediately prior to the Effective Time. The shares of Class A Common Stock have no expiration date. F6 · derivative.expiration_date: Each share of Class A Common Stock converted into one (1) share of Class B Common Stock at the Effective Time. Read SEC document |
| February 17, 2022 Filed Feb 18, 2022 14:08 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Disposition to issuerDirector Stock Option (right to buy) · Derivative | 25,000 | Not disclosed Strike: $16.00 | Not disclosed |
DisclosureSEC source: 0001209191-22-011148 · doc4.xml · derivative · entry 3 EBERSMAN DAVID A · CIK 0001214123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 25,000 shares Expires 2024-03-12 F4 · price: The option exercise price is equal to or exceeds the Merger Consideration and therefore the option was automatically cancelled without consideration immediately prior to the Effective Time. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| February 17, 2022 Filed Feb 18, 2022 14:08 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Disposition to issuerClass B Common Stock | 630,803 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-011148 · doc4.xml · nonDerivative · entry 2 EBERSMAN DAVID A · CIK 0001214123 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 0 F1 · price: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated January 4, 2022, by and among the Issuer, Vera Whole Health, Inc. ("Vera Health"), and Carbon Merger Sub, Inc. (the "Merger Sub"), the Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Vera Health, effective as of February 17, 2022 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the Issuer's Class A common stock and Class B common stock was exchanged for $2.05 in cash (the "Merger Consideration") at the Effective Time. F2 · ownership.nature: The shares are held by The Ebersman Family Trust UTA dated 5/29/2002 of which the Reporting Person and his wife are co-trustees. Read SEC document |
| February 17, 2022 Filed Feb 18, 2022 14:08 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Disposition to issuerClass B Common Stock | 35,354 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-011148 · doc4.xml · nonDerivative · entry 1 EBERSMAN DAVID A · CIK 0001214123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated January 4, 2022, by and among the Issuer, Vera Whole Health, Inc. ("Vera Health"), and Carbon Merger Sub, Inc. (the "Merger Sub"), the Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Vera Health, effective as of February 17, 2022 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the Issuer's Class A common stock and Class B common stock was exchanged for $2.05 in cash (the "Merger Consideration") at the Effective Time. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 20:57 UTC | MOMENTIVE GLOBAL INC. MNTV · Entity 112784 | GrantStock Option (Right to Buy) · Derivative | 6,914 | $0.00 Strike: $21.53 | $0.00 |
DisclosureSEC source: 0001209191-21-050732 · doc4.xml · derivative · entry 2 EBERSMAN DAVID A · CIK 0001214123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,914 Underlying: Common Stock · 6,914 shares Expires 2031-08-06 F3 · derivative.exercise_date: Grant of Stock Options ("NSOs"). 1/4th of the total number of NSOs will vest on 08/15/2021 and 1/4th of the total number of NSOs will vest quarterly thereafter, subject to the Reporting Person's continued service to the Company until fully vested. Read SEC document |
| July 12, 2021 Filed Jul 14, 2021 19:19 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | ConversionClass A Common Stock · Derivative | 260,973 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-046703 · doc4.xml · derivative · entry 5 EBERSMAN DAVID A · CIK 0001214123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,571 Underlying: Class B Common Stock · 260,973 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of issuer's Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class A Common Stock have no expiration date. F2 · derivative.exercise_price: Each share of the issuer's Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the earliest to occur of the following: (a) the first date on which the number of shares of Class A Common Stock then outstanding is less than 15,340,384 shares, (b) March 19, 2024, or (c) a time and date approved in writing by holders of at least a majority of the then-outstanding shares of Class A Common Stock. F1 · derivative.exercise_date: Each share of issuer's Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class A Common Stock have no expiration date. F2 · derivative.exercise_date: Each share of the issuer's Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the earliest to occur of the following: (a) the first date on which the number of shares of Class A Common Stock then outstanding is less than 15,340,384 shares, (b) March 19, 2024, or (c) a time and date approved in writing by holders of at least a majority of the then-outstanding shares of Class A Common Stock. F1 · derivative.expiration_date: Each share of issuer's Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class A Common Stock have no expiration date. F2 · derivative.expiration_date: Each share of the issuer's Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the earliest to occur of the following: (a) the first date on which the number of shares of Class A Common Stock then outstanding is less than 15,340,384 shares, (b) March 19, 2024, or (c) a time and date approved in writing by holders of at least a majority of the then-outstanding shares of Class A Common Stock. Read SEC document |
| July 12, 2021 Filed Jul 14, 2021 19:19 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass A Common Stock · Derivative | 260,973 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-046703 · doc4.xml · derivative · entry 4 EBERSMAN DAVID A · CIK 0001214123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289,544 Underlying: Class B Common Stock · 260,973 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of issuer's Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class A Common Stock have no expiration date. F2 · derivative.exercise_price: Each share of the issuer's Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the earliest to occur of the following: (a) the first date on which the number of shares of Class A Common Stock then outstanding is less than 15,340,384 shares, (b) March 19, 2024, or (c) a time and date approved in writing by holders of at least a majority of the then-outstanding shares of Class A Common Stock. F1 · derivative.exercise_date: Each share of issuer's Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class A Common Stock have no expiration date. F2 · derivative.exercise_date: Each share of the issuer's Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the earliest to occur of the following: (a) the first date on which the number of shares of Class A Common Stock then outstanding is less than 15,340,384 shares, (b) March 19, 2024, or (c) a time and date approved in writing by holders of at least a majority of the then-outstanding shares of Class A Common Stock. F1 · derivative.expiration_date: Each share of issuer's Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class A Common Stock have no expiration date. F2 · derivative.expiration_date: Each share of the issuer's Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the earliest to occur of the following: (a) the first date on which the number of shares of Class A Common Stock then outstanding is less than 15,340,384 shares, (b) March 19, 2024, or (c) a time and date approved in writing by holders of at least a majority of the then-outstanding shares of Class A Common Stock. Read SEC document |
| July 12, 2021 Filed Jul 14, 2021 19:19 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionDirector Stock Option (right to buy) · Derivative | 260,973 | $0.00 Strike: $0.84 | $0.00 |
DisclosureSEC source: 0001209191-21-046703 · doc4.xml · derivative · entry 3 EBERSMAN DAVID A · CIK 0001214123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 260,973 shares Expires 2021-07-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock option has fully vested and is immediately exercisable. F1 · derivative.underlying: Each share of issuer's Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class A Common Stock have no expiration date. F2 · derivative.underlying: Each share of the issuer's Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the earliest to occur of the following: (a) the first date on which the number of shares of Class A Common Stock then outstanding is less than 15,340,384 shares, (b) March 19, 2024, or (c) a time and date approved in writing by holders of at least a majority of the then-outstanding shares of Class A Common Stock. Read SEC document |
| July 12, 2021 Filed Jul 14, 2021 19:19 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | ConversionClass B Common Stock | 260,973 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-046703 · doc4.xml · nonDerivative · entry 1 EBERSMAN DAVID A · CIK 0001214123 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 595,450 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of issuer's Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class A Common Stock have no expiration date. F2 · price: Each share of the issuer's Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the earliest to occur of the following: (a) the first date on which the number of shares of Class A Common Stock then outstanding is less than 15,340,384 shares, (b) March 19, 2024, or (c) a time and date approved in writing by holders of at least a majority of the then-outstanding shares of Class A Common Stock. F3 · balance_after: 334,477 shares previously reported as held directly by the Reporting Person are held by the family trust and are reflected as such in this Form 4. F4 · ownership.nature: The shares are held by The Ebersman Family Trust UTA dated 5/29/2002 of which the Reporting Person and his wife are co-trustees. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 19:02 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | GrantClass B Common Stock | 70,707 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040372 · doc4.xml · nonDerivative · entry 1 EBERSMAN DAVID A · CIK 0001214123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 405,184 F1 · shares: Represents an award of restricted stock units ("RSUs"). 25% of the RSUs will vest on August 16, 2021, and the remaining 75% of the RSUs will vest in 3 equal quarterly installments thereafter beginning on November 16, 2021. Each RSU represents a contingent right to receive one share of the Issuer's Class B common stock upon settlement for no consideration. Read SEC document |
| June 02, 2021 Filed Aug 10, 2021 20:57 UTC | MOMENTIVE GLOBAL INC. MNTV · Entity 112784 | GrantCommon Stock | 3,457 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-050732 · doc4.xml · nonDerivative · entry 1 EBERSMAN DAVID A · CIK 0001214123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,088 F1 · shares: Grant of Restricted Stock Units ("RSUs") 1/4th of the total number of RSUs will vest on 08/15/2021 and 1/4th of the total number of RSUs will vest quarterly thereafter, subject to the Reporting Person's continued service to the Company until fully vested. F2 · balance_after: Certain of these securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the applicable vesting schedule and conditions. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 18:09 UTC | MOMENTIVE GLOBAL INC. SVMK · Entity 112784 | GrantStock Option (Right to Buy) · Derivative | 9,070 | $0.00 Strike: $21.74 | $0.00 |
DisclosureSEC source: 0001209191-20-046440 · doc4.xml · derivative · entry 1 EBERSMAN DAVID A · CIK 0001214123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,070 Underlying: Common Stock · 9,070 shares Expires 2030-08-10 F1 · derivative.exercise_date: Grant of Stock Options ("NSOs"). 1/4th of the total number of NSOs will vest on 08/15/2020 and 1/4th of the total number of NSOs will vest quarterly thereafter, subject to the Reporting Person's continued service to the Company until fully vested. Read SEC document |
| June 04, 2020 Filed Jun 8, 2020 20:59 UTC | MOMENTIVE GLOBAL INC. SVMK · Entity 112784 | GrantCommon Stock | 4,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-035167 · doc4.xml · nonDerivative · entry 1 EBERSMAN DAVID A · CIK 0001214123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,631 F1 · shares: Grant of Restricted Stock Units ("RSUs") 1/4th of the total number of RSUs will vest on 08/15/2020 and 1/4th of the total number of RSUs will vest quarterly thereafter, subject to the Reporting Person's continued service to the Company until fully vested. F2 · balance_after: Certain of these securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the applicable vesting schedule and conditions. Read SEC document |
| June 03, 2020 Filed Jun 5, 2020 17:47 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | GrantClass B Common Stock | 180,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-034754 · doc4.xml · nonDerivative · entry 1 EBERSMAN DAVID A · CIK 0001214123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 334,477 F1 · shares: Represents an award of restricted stock units ("RSUs"). 25% of the RSUs will vest on August 16, 2020, and the remaining 75% of the RSUs will vest in 3 equal quarterly installments thereafter beginning on November 16, 2020. Each RSU represents a contingent right to receive one share of the Issuer's Class B common stock upon settlement for no consideration. Read SEC document |
| August 05, 2019 Filed Aug 7, 2019 19:16 UTC | MOMENTIVE GLOBAL INC. SVMK · Entity 112784 | GrantStock Option (Right to Buy) · Derivative | 10,192 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001209191-19-045028 · doc4.xml · derivative · entry 1 EBERSMAN DAVID A · CIK 0001214123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,192 Underlying: Common Stock · 10,192 shares Expires 2029-08-05 F1 · derivative.exercise_date: Grant of Stock Options ("NSOs"). 1/4th of the total number of NSOs will vest on 08/15/2019 and 1/4th of the total number of NSOs will vest quarterly thereafter for the remaining 3 quarters, subject to the Reporting Person's continued service to the Company until fully vested. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 17:29 UTC | MOMENTIVE GLOBAL INC. SVMK · Entity 112784 | GrantCommon Stock | 5,096 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-036876 · doc4.xml · nonDerivative · entry 1 EBERSMAN DAVID A · CIK 0001214123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,096 F1 · shares: Grant of Restricted Stock Units ("RSUs") 1/4th of the total number of RSUs will vest on 08/15/2019 and 1/4th of the total number of RSUs will vest quarterly thereafter for the remaining 3 quarters, subject to the Reporting Person's continued service to the Company until fully vested. F2 · balance_after: Certain of these securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the applicable vesting schedule and conditions. Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 18:56 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | GrantClass B Common Stock | 44,164 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-013098 · doc1.xml · nonDerivative · entry 1 EBERSMAN DAVID A · CIK 0001214123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,832 F1 · shares: Represents an award of restricted stock units ("RSUs"). 25% of the RSUs will vest on August 16, 2019, and the remaining 75% of the RSUs will vest in 3 equal quarterly installments thereafter beginning on November 16, 2019. Each RSU represents a contingent right to receive one share of the Issuer's Class B common stock upon settlement for no consideration. Read SEC document |
| June 20, 2018 Filed Jun 22, 2018 19:22 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | GrantClass B Common Stock | 32,183 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-029665 · doc1.xml · nonDerivative · entry 1 EBERSMAN DAVID A · CIK 0001214123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,668 F1 · shares: Represents an award of restricted stock units ("RSUs"). 25% of the RSUs will vest on August 16, 2018, and the remaining 75% of the RSUs will vest in 3 equal quarterly installments thereafter beginning on November 16, 2018. Each RSU represents a contingent right to receive one share of the Issuer's Class B common stock upon settlement for no consideration. Read SEC document |
| June 22, 2017 Filed Jun 26, 2017 19:25 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | GrantClass B Common Stock | 33,735 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-026122 · doc1.xml · nonDerivative · entry 1 EBERSMAN DAVID A · CIK 0001214123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,485 F1 · shares: Represents an award of restricted stock units ("RSUs"). 25% of the RSUs will vest on September 22, 2017 and an additional 25% will vest on each quarterly anniversary thereafter. Each RSU represents a contingent right to receive one share of the Issuer's Class B common stock upon settlement for no consideration. Read SEC document |
| May 29, 2014 Filed May 30, 2014 18:06 UTC | Meta Platforms, Inc. FB · Entity 2790 | SaleClass A Common Stock | 11,700 | $63.86 | $747,162.00 |
DisclosureSEC source: 0001209191-14-038085 · doc4.xml · nonDerivative · entry 2 EBERSMAN DAVID A · CIK 0001214123 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 328,030 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| May 28, 2014 Filed May 30, 2014 18:06 UTC | Meta Platforms, Inc. FB · Entity 2790 | SaleClass A Common Stock | 11,700 | $63.38 | $741,546.00 |
DisclosureSEC source: 0001209191-14-038085 · doc4.xml · nonDerivative · entry 1 EBERSMAN DAVID A · CIK 0001214123 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,730 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| May 15, 2014 Filed May 19, 2014 20:29 UTC | Meta Platforms, Inc. FB · Entity 2790 | ConversionClass B Common Stock · Derivative | 112,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-14-035352 · doc4.xml · derivative · entry 8 EBERSMAN DAVID A · CIK 0001214123 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 112,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · security: The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares, and has no expiration date. F9 · derivative.exercise_price: The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares, and has no expiration date. F10 · shares: The holder elected to convert the shares of Class B Common Stock into Class A Common Stock on a 1-for-1 basis. F9 · derivative.exercise_date: The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares, and has no expiration date. F9 · derivative.expiration_date: The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares, and has no expiration date. Read SEC document |
| May 15, 2014 Filed May 19, 2014 20:29 UTC | Meta Platforms, Inc. FB · Entity 2790 | Exercise / conversionClass B Common Stock · Derivative | 112,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-14-035352 · doc4.xml · derivative · entry 7 EBERSMAN DAVID A · CIK 0001214123 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,500 Underlying: Class A Common Stock · 112,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · security: The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares, and has no expiration date. F9 · derivative.exercise_price: The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares, and has no expiration date. F9 · derivative.exercise_date: The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares, and has no expiration date. F9 · derivative.expiration_date: The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares, and has no expiration date. Read SEC document |
| May 15, 2014 Filed May 19, 2014 20:29 UTC | Meta Platforms, Inc. FB · Entity 2790 | Exercise / conversionRestricted Stock Units (RSU) · Derivative | 112,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-14-035352 · doc4.xml · derivative · entry 6 EBERSMAN DAVID A · CIK 0001214123 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Underlying: Class B Common Stock · 112,500 shares Expires 2019-10-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the issuer's Class B Common Stock upon settlement. F8 · derivative.exercise_date: The RSUs were granted with both (a) a liquidity event-based vesting condition and (b) a service-based vesting condition, both of which conditions must be satisfied in order for the RSUs to vest. The liquidity event-based vesting condition was satisfied on November 17, 2012. The service-based vesting condition was satisfied as to 1/5th of the total number of shares on September 15, 2010 and then 1/60th of the total number of shares vest monthly thereafter, subject to continued service through each vesting date. F9 · derivative.underlying: The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares, and has no expiration date. Read SEC document |
| May 15, 2014 Filed May 19, 2014 20:29 UTC | Meta Platforms, Inc. FB · Entity 2790 | SaleClass A Common Stock | 8,115 | $59.11 | $479,641.94 |
DisclosureSEC source: 0001209191-14-035352 · doc4.xml · nonDerivative · entry 3 EBERSMAN DAVID A · CIK 0001214123 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 351,430 F2 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs listed in Table II. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.91 to $59.26 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4). Read SEC document |
| May 15, 2014 Filed May 19, 2014 20:29 UTC | Meta Platforms, Inc. FB · Entity 2790 | SaleClass A Common Stock | 50,600 | $58.33 | $2,951,437.28 |
DisclosureSEC source: 0001209191-14-035352 · doc4.xml · nonDerivative · entry 2 EBERSMAN DAVID A · CIK 0001214123 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,545 F2 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs listed in Table II. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.90 to $58.89 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3). Read SEC document |
| May 15, 2014 Filed May 19, 2014 20:29 UTC | Meta Platforms, Inc. FB · Entity 2790 | ConversionClass A Common Stock | 112,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-14-035352 · doc4.xml · nonDerivative · entry 1 EBERSMAN DAVID A · CIK 0001214123 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 410,145 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the number of shares that were acquired upon conversion of Class B Common Stock to Class A Common Stock in connection with the settlement of the restricted stock units (the "RSUs") listed in Table II. Read SEC document |
| May 13, 2014 Filed May 14, 2014 17:52 UTC | Meta Platforms, Inc. FB · Entity 2790 | SaleClass A Common Stock | 11,700 | $59.65 | $697,905.00 |
DisclosureSEC source: 0001209191-14-033814 · doc4.xml · nonDerivative · entry 2 EBERSMAN DAVID A · CIK 0001214123 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,645 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| May 12, 2014 Filed May 14, 2014 17:52 UTC | Meta Platforms, Inc. FB · Entity 2790 | SaleClass A Common Stock | 11,700 | $58.07 | $679,419.00 |
DisclosureSEC source: 0001209191-14-033814 · doc4.xml · nonDerivative · entry 1 EBERSMAN DAVID A · CIK 0001214123 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 309,345 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| May 06, 2014 Filed May 8, 2014 18:50 UTC | Meta Platforms, Inc. FB · Entity 2790 | ConversionClass B Common Stock · Derivative | 13,742 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-14-032390 · doc4.xml · derivative · entry 6 EBERSMAN DAVID A · CIK 0001214123 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 13,742 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares, and has no expiration date. F5 · derivative.exercise_price: The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares, and has no expiration date. F6 · shares: The holder elected to convert the shares of Class B Common Stock into Class A Common Stock on a 1-for-1 basis. F5 · derivative.exercise_date: The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares, and has no expiration date. F5 · derivative.expiration_date: The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares, and has no expiration date. Read SEC document |
| May 06, 2014 Filed May 8, 2014 18:50 UTC | Meta Platforms, Inc. FB · Entity 2790 | Exercise / conversionClass B Common Stock · Derivative | 13,742 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-14-032390 · doc4.xml · derivative · entry 5 EBERSMAN DAVID A · CIK 0001214123 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,742 Underlying: Class A Common Stock · 13,742 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares, and has no expiration date. F5 · derivative.exercise_price: The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares, and has no expiration date. F5 · derivative.exercise_date: The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares, and has no expiration date. F5 · derivative.expiration_date: The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares, and has no expiration date. Read SEC document |
| May 06, 2014 Filed May 8, 2014 18:50 UTC | Meta Platforms, Inc. FB · Entity 2790 | Exercise / conversionStock Option (Right to Buy Class B Common Stock) · Derivative | 13,742 | $0.00 Strike: $3.23 | $0.00 |
DisclosureSEC source: 0001209191-14-032390 · doc4.xml · derivative · entry 4 EBERSMAN DAVID A · CIK 0001214123 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,362,578 Underlying: Class B Common Stock · 13,742 shares Expires 2019-10-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option was vested as to 1/5th of the total shares on September 8, 2010 after which 1/60th of the total shares vest monthly, subject to continued service through each vesting date. F5 · derivative.underlying: The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares, and has no expiration date. Read SEC document |
| May 06, 2014 Filed May 8, 2014 18:50 UTC | Meta Platforms, Inc. FB · Entity 2790 | ConversionClass A Common Stock | 13,742 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-14-032390 · doc4.xml · nonDerivative · entry 1 EBERSMAN DAVID A · CIK 0001214123 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321,045 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the number of shares that were acquired upon conversion of Class B Common Stock to Class A Common Stock at the election of the holder. Read SEC document |
| April 30, 2014 Filed May 1, 2014 18:07 UTC | Meta Platforms, Inc. FB · Entity 2790 | SaleClass A Common Stock | 11,700 | $57.56 | $673,452.00 |
DisclosureSEC source: 0001209191-14-030276 · doc4.xml · nonDerivative · entry 2 EBERSMAN DAVID A · CIK 0001214123 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 307,303 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 29, 2014 Filed May 1, 2014 18:07 UTC | Meta Platforms, Inc. FB · Entity 2790 | SaleClass A Common Stock | 11,700 | $56.08 | $656,136.00 |
DisclosureSEC source: 0001209191-14-030276 · doc4.xml · nonDerivative · entry 1 EBERSMAN DAVID A · CIK 0001214123 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 319,003 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 16, 2014 Filed Apr 17, 2014 18:02 UTC | Meta Platforms, Inc. FB · Entity 2790 | SaleClass A Common Stock | 11,700 | $59.81 | $699,777.00 |
DisclosureSEC source: 0001209191-14-028247 · doc4.xml · nonDerivative · entry 5 EBERSMAN DAVID A · CIK 0001214123 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 330,703 F5 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 15, 2014 Filed Apr 17, 2014 18:02 UTC | Meta Platforms, Inc. FB · Entity 2790 | ConversionClass B Common Stock · Derivative | 112,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-14-028247 · doc4.xml · derivative · entry 10 EBERSMAN DAVID A · CIK 0001214123 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 112,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · security: The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares, and has no expiration date. F10 · derivative.exercise_price: The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares, and has no expiration date. F11 · shares: The holder elected to convert the shares of Class B Common Stock into Class A Common Stock on a 1-for-1 basis. F10 · derivative.exercise_date: The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares, and has no expiration date. F10 · derivative.expiration_date: The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares, and has no expiration date. Read SEC document |
| April 15, 2014 Filed Apr 17, 2014 18:02 UTC | Meta Platforms, Inc. FB · Entity 2790 | Exercise / conversionClass B Common Stock · Derivative | 112,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-14-028247 · doc4.xml · derivative · entry 9 EBERSMAN DAVID A · CIK 0001214123 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,500 Underlying: Class A Common Stock · 112,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · security: The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares, and has no expiration date. F10 · derivative.exercise_price: The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares, and has no expiration date. F10 · derivative.exercise_date: The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares, and has no expiration date. F10 · derivative.expiration_date: The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares, and has no expiration date. Read SEC document |
| April 15, 2014 Filed Apr 17, 2014 18:02 UTC | Meta Platforms, Inc. FB · Entity 2790 | Exercise / conversionRestricted Stock Units (RSU) · Derivative | 112,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-14-028247 · doc4.xml · derivative · entry 8 EBERSMAN DAVID A · CIK 0001214123 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 562,500 Underlying: Class B Common Stock · 112,500 shares Expires 2019-10-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the issuer's Class B Common Stock upon settlement. F9 · derivative.exercise_date: The RSUs were granted with both (a) a liquidity event-based vesting condition and (b) a service-based vesting condition, both of which conditions must be satisfied in order for the RSUs to vest. The liquidity event-based vesting condition was satisfied on November 17, 2012. The service-based vesting condition was satisfied as to 1/5th of the total number of shares on September 15, 2010 and then 1/60th of the total number of shares vest monthly thereafter, subject to continued service through each vesting date. F10 · derivative.underlying: The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares, and has no expiration date. Read SEC document |
| April 15, 2014 Filed Apr 17, 2014 18:02 UTC | Meta Platforms, Inc. FB · Entity 2790 | SaleClass A Common Stock | 11,700 | $59.29 | $693,693.00 |
DisclosureSEC source: 0001209191-14-028247 · doc4.xml · nonDerivative · entry 4 EBERSMAN DAVID A · CIK 0001214123 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 342,403 F5 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 15, 2014 Filed Apr 17, 2014 18:02 UTC | Meta Platforms, Inc. FB · Entity 2790 | SaleClass A Common Stock | 25,714 | $59.39 | $1,527,113.32 |
DisclosureSEC source: 0001209191-14-028247 · doc4.xml · nonDerivative · entry 3 EBERSMAN DAVID A · CIK 0001214123 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,103 F2 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs listed in Table II. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.16 to $59.65 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4). Read SEC document |
| April 15, 2014 Filed Apr 17, 2014 18:02 UTC | Meta Platforms, Inc. FB · Entity 2790 | SaleClass A Common Stock | 33,000 | $58.78 | $1,939,591.50 |
DisclosureSEC source: 0001209191-14-028247 · doc4.xml · nonDerivative · entry 2 EBERSMAN DAVID A · CIK 0001214123 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 379,817 F2 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs listed in Table II. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.16 to $59.15 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3). Read SEC document |
| April 15, 2014 Filed Apr 17, 2014 18:02 UTC | Meta Platforms, Inc. FB · Entity 2790 | ConversionClass A Common Stock | 112,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-14-028247 · doc4.xml · nonDerivative · entry 1 EBERSMAN DAVID A · CIK 0001214123 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 412,817 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the number of shares that were acquired upon conversion of Class B Common Stock to Class A Common Stock in connection with the settlement of the restricted stock units (the "RSUs") listed in Table II. Read SEC document |
| April 03, 2014 Filed Apr 3, 2014 18:39 UTC | Meta Platforms, Inc. FB · Entity 2790 | SaleClass A Common Stock | 11,700 | $62.53 | $731,601.00 |
DisclosureSEC source: 0001209191-14-025721 · doc4.xml · nonDerivative · entry 2 EBERSMAN DAVID A · CIK 0001214123 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,317 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 02, 2014 Filed Apr 3, 2014 18:39 UTC | Meta Platforms, Inc. FB · Entity 2790 | SaleClass A Common Stock | 11,700 | $63.24 | $739,908.00 |
DisclosureSEC source: 0001209191-14-025721 · doc4.xml · nonDerivative · entry 1 EBERSMAN DAVID A · CIK 0001214123 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312,017 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| March 19, 2014 Filed Mar 20, 2014 18:57 UTC | Meta Platforms, Inc. FB · Entity 2790 | SaleClass A Common Stock | 11,700 | $69.13 | $808,821.00 |
DisclosureSEC source: 0001209191-14-022304 · doc4.xml · nonDerivative · entry 2 EBERSMAN DAVID A · CIK 0001214123 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 323,717 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| March 18, 2014 Filed Mar 20, 2014 18:57 UTC | Meta Platforms, Inc. FB · Entity 2790 | SaleClass A Common Stock | 11,700 | $68.75 | $804,375.00 |
DisclosureSEC source: 0001209191-14-022304 · doc4.xml · nonDerivative · entry 1 EBERSMAN DAVID A · CIK 0001214123 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335,417 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.